Raymond Comenzo
Tufts University
H-index: 64
North America-United States
Top articles of Raymond Comenzo
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Renal Response Criteria for Clinical Trials in Amyloid Light Chain Amyloidosis | Nelson Leung Raymond Comenzo Julian Gillmore Andrea Havasi Efstathios Kastritis | 2024/4/4 | |
P56 SURVIVAL BENEFIT OF BIRTAMIMAB IN MAYO STAGE IV AL AMYLOIDOSIS IN THE PHASE 3 VITAL STUDY WAS CONSISTENT ACROSS ALL KEY BASELINE VARIABLES | HemaSphere | M Gertz A Cohen R Comenzo E Kastritis H Landau | 2023/5/1 |
Histologic and Molecular Correlates in Patients with AL Amyloidosis in Hematologic Remission but with Persistent Renal Disease | Blood | Cindy Varga Felix Eichinger Abhijit Naik Viji Nair Samih Nasr | 2023/11/28 |
Quality of life and symptoms among patients with relapsed/refractory AL amyloidosis treated with ixazomib‐dexamethasone versus physician's choice | American journal of hematology | Vaishali Sanchorawala Ashutosh D Wechalekar Kihyun Kim Stefan O Schönland Heather J Landau | 2023/5 |
Bone Marrow Interstitial Light-Chain Amyloid and Its Microenvironment | Blood | Ping Zhou Tanya Karagiannis Albert Tai Xun Ma Denis Toskic | 2023/11/28 |
Therapeutic plasma exchange decreases plasma anti‐SARS‐CoV‐2 spike IgG without increasing the proximate incidence of COVID‐19 | Journal of Clinical Apheresis | Jensyn Cone Sullivan Steven E Conklin Stephanie Conrad Coby Horowitz Mark Diethelm | 2023/12 |
Birtamimab plus standard of care in light-chain amyloidosis: the phase 3 randomized placebo-controlled VITAL trial | Blood | Morie A Gertz Adam D Cohen Raymond L Comenzo Efstathios Kastritis Heather J Landau | 2023/10/5 |
Effect of Patisiran on Polyneuropathy and Cardiomyopathy in Patients with hATTR Amyloidosis with V122I/T60A Variants: A Phase 4 Observational Study (S14. 005) | Raymond L Comenzo Francy Shu Saurabh Malhotra Yessar Hussain Ronald Zolty | 2023/4/25 | |
Teclistamab Induces Rapid Responses in Patients with Relapsed/Refractory AL Amyloidosis | Blood | Hashim Mann Denis Toskic Karen Pak Patrick Willard Teresa Fogaren | 2023/11/28 |
Daratumumab plus bortezomib, cyclophosphamide, and dexamethasone in Asian patients with newly diagnosed AL amyloidosis: subgroup analysis of ANDROMEDA | Annals of Hematology | Kenshi Suzuki Ashutosh D Wechalekar Kihyun Kim Chihiro Shimazaki Jin Seok Kim | 2023/4 |
Impact of cytogenetic abnormalities on treatment outcomes in patients with amyloid light-chain amyloidosis: subanalyses from the ANDROMEDA study | Amyloid | Shaji Kumar Angela Dispenzieri Divaya Bhutani Morie Gertz Ashutosh Wechalekar | 2023/7/3 |
Using Next Generation Sequencing to Identify Trackable Clonotypic Sequences for Minimal Residual Disease Testing in AL Amyloidosis | Blood | Xia Wu Ping Zhou Sandy W Wong Benjamin Rosenthal Alfred Chung | 2023/11/28 |
Pooled Analysis of Safety from Birtamimab Phase 1-3 Studies in Patients with Light Chain (AL) Amyloidosis | Blood | Vaishali Sanchorawala Ashutosh D Wechalekar Efstathios Kastritis Giovanni Palladini Stefan Schönland | 2023/11/28 |
PCR131 Expanded Diagnoses Outside of Specialized Amyloidosis Centers: Results from the Amyloidosis Research Consortium's 2022 Community Survey | Value in Health | S Rebello K Hsu SA Tuchman BW Sperry MS Maurer | 2023/6/1 |
Relapsed/refractory multiple myeloma: A review of available therapies and clinical scenarios encountered in myeloma relapse | Parva Bhatt Colin Kloock Raymond Comenzo | 2023/2/15 | |
Population pharmacokinetics and exposure‐response modeling of daratumumab subcutaneous administration in patients with light‐chain amyloidosis | British Journal of Clinical Pharmacology | Yangang Zhou Ping Xu Huande Li Feng Wang Han Yan | 2021/7 |
Outcomes of patients with multiple myeloma harboring chromosome 1q gain/amplification in the era of modern therapy | Annals of Hematology | Xiao Hu Cherng-Horng Wu Janet M Cowan Raymond L Comenzo Cindy Varga | 2022/2 |
Belantamab mafodotin in patients with relapsed/refractory AL amyloidosis with myeloma | Annals of Hematology | Yifei Zhang Amandeep Godara Stacey Pan Denis Toskic Hashim Mann | 2022/9 |
Peripheral agglutination and hemolytic anemia following minor ABO-mismatch hematopoietic progenitor cell transplantation | Blood, The Journal of the American Society of Hematology | Jensyn Cone Sullivan Raymond Comenzo | 2022/12/1 |
Laboratory-Based Rationale for Targeting the Protein Homeostasis Network in AL Amyloidosis | Giada Bianchi Maria Moscvin Raymond L Comenzo | 2022/4/25 |
